ophthalmology
Biocon Biologics Gains Health Canada Approval for Yesafili™ (Aflibercept): Exciting Launch Planned for July 2025!
Biocon Biologics Launches YESAFILI in Canada Big news for Canadian patients! Biocon Biologics Ltd. has received approval from Health Canada ... Read more
Revolutionary Contact Lens Breakthrough at Waseda University: A Game-Changer in Vision Care
New MXene-Coated Contact Lenses Offer Protection from Electromagnetic Radiation With the rise of smart contact lenses, concerns about eye health ... Read more
Unlocking Heart Health: How Your Lifestyle Choices Impact Cardiovascular Disease Risk
Cardiovascular disease (CVD) is a significant health issue. In fact, it’s the leading cause of death worldwide. The American Heart ... Read more
Empowering Clinicians: How the CARD Initiative Transforms Care Through Social Determinants of Health
Some of the biggest factors affecting health are related to our living conditions and social life, such as housing, access ... Read more
Transform Your Life: Effective Lifestyle Interventions for Mastering MASH Management
On March 14, 2024, the FDA made a groundbreaking decision. It approved resmetirom, also known as Rezdiffra, from Madrigal Pharmaceuticals. ... Read more
Breaking New Ground: Innovative Strategies for Managing Pediatric Food Allergies and Anaphylaxis
In a recent panel discussion on pediatric food allergies, leading experts shared insights on the latest advancements in managing these ... Read more
